KR

Krishnamraju Rudraraju

Active Director Director DIN 09633965
DIN 09633965 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Krishnamraju Rudraraju

Data last updated:

Krishnamraju Rudraraju is a Director at Sancus Medical Systems Private Limited (since 2022). The company operates in Chemicals. Sancus Medical Systems Private Limited reported revenue of ₹1.97 Cr (FY 2025).

DIN 09633965
Primary Designation Director
Industry Chemicals
First Appointment 10 Jun 2022
Oldest Company Age 4 yrs
Largest company Sancus Medical Systems Private Limited · ₹1.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jun 20222022₹1.97 Cr (FY 2025)Active

Board colleagues of Krishnamraju Rudraraju

Directorship timeline

Open interactive timeline →
Sancus Medical Systems Private Limited
Premium access

Shareholding and investment profile for Krishnamraju Rudraraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnamraju Rudraraju

Krishnamraju Rudraraju currently holds 1 directorship: Sancus Medical Systems Private Limited (Director, since 10 Jun 2022, revenue ₹1.97 Cr (FY 2025)).

Krishnamraju Rudraraju was first appointed on 10 Jun 2022 as Director at Sancus Medical Systems Private Limited.

The current boards of Krishnamraju Rudraraju's companies include Mandha Kishore Kumar Reddy (Sancus Medical Systems Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available